Role of altered beta-adrenoceptor signal transduction in the pathogenesis of cirrhotic cardiomyopathy in rats.
about
Left ventricular function assessment in cirrhosis: Current methods and future directions.Cirrhotic cardiomyopathyCardiovascular dysfunction in patients with liver cirrhosisCardiopulmonary dysfunction in cirrhosis.In vivo and ex vivo effects of propofol on myocardial performance in rats with obstructive jaundice.Cardiac function in patients with early cirrhosis during maximal beta-adrenergic drive: a dobutamine stress study.Cirrhotic cardiomyopathy: a pathophysiological review of circulatory dysfunction in liver diseaseManagement of cardiopulmonary complications of cirrhosis.Effect of meal induced splanchnic arterial vasodilatation on renal arterial haemodynamics in normal subjects and patients with cirrhosis.Cardiac function and haemodynamics in alcoholic cirrhosis and effects of the transjugular intrahepatic portosystemic stent shunt.The cardiac response to exercise in cirrhosis.Increased circulating pro-brain natriuretic peptide (proBNP) and brain natriuretic peptide (BNP) in patients with cirrhosis: relation to cardiovascular dysfunction and severity of disease.Reversible Cardiomyopathies.Cardiac and vascular changes in cirrhosis: pathogenic mechanisms.Therapy insight: Cirrhotic cardiomyopathy.Contribution of mammalian target of rapamycin in the pathophysiology of cirrhotic cardiomyopathy.Blunted cardiac response to hemorrhage in cirrhotic rats is mediated by local macrophage-released endocannabinoidsThe heart and the liver.Minocycline attenuates cirrhotic cardiomyopathy and portal hypertension in a rat model: Possible involvement of nitric oxide pathwayCardiac dysfunction in cirrhosis - does adrenal function play a role? A hypothesis.Cardiohepatic syndrome.Cirrhotic cardiomyopathy: a cardiologist's perspective.Recent advances in cirrhotic cardiomyopathy.Origins of cardiac dysfunction in cirrhosis.Hypertrophic cardiomyopathy and dysregulation of cardiac energetics in a mouse model of biliary fibrosisRole of endocannabinoids in the pathogenesis of cirrhotic cardiomyopathy in bile duct-ligated rats.Cardiac excitation-contraction coupling in the portal hypertensive rat.Hemodynamic effects of the early and long-term administration of propranolol in rats with intrahepatic portal hypertension.A murine model of alcoholic cardiomyopathy: a role for zinc and metallothionein in fibrosis.Role of heme oxygenase-carbon monoxide pathway in pathogenesis of cirrhotic cardiomyopathy in the rat.Involvement of endogenous opioid peptides and nitric oxide in the blunted chronotropic and inotropic responses to beta-adrenergic stimulation in cirrhotic rats.Diastolic and autonomic dysfunction in early cirrhosis: a dobutamine stress study.Frequency and severity of cirrhotic cardiomyopathy and its possible relationship with bacterial endotoxemia.An abnormal gene expression of the beta-adrenergic system contributes to the pathogenesis of cardiomyopathy in cirrhotic rats.Diastolic dysfunction is a predictor of poor outcomes in patients with cirrhosis, portal hypertension, and a normal creatinine.
P2860
Q26769598-338B601E-9F35-4F37-9F25-C3AE25ED5EFDQ26778048-99F610FF-35C8-4AAC-809C-9959175C434CQ27010592-0B825DBA-F6AF-47BD-9AEA-E634B8428FBAQ33672187-3269989A-C68D-4F67-ACE2-12CEF4DF7144Q34113031-27052D05-3F05-4FFF-8F8E-41455A56F882Q34287422-5D1F92DD-FF4D-48BF-9CB5-00F21E670A24Q34467402-EDE2E644-7BBB-481E-8341-DCE45AFABF72Q35207515-56536EDD-1AE1-4BF6-B537-11873E5C9B19Q35353737-457C055C-F85A-42E5-80F5-9B6AC4DA5606Q35355011-24F0431B-B257-4A25-B41C-5F43705A3795Q35364575-B0BDB44D-36B2-4396-88DD-15E72D7E2373Q35596013-F5764361-292F-431D-985E-97BC749D8A8FQ35636735-89E97D3E-79C0-4752-BA6B-84121ED9C346Q36415452-009366E7-DCEE-46B0-A73A-81FDC297248BQ36495176-64467958-BC22-4E06-97D4-D3C5417605E6Q36909237-7ADDC536-631E-47C6-B852-DD21F4DA10D5Q37301437-30E6EC7B-8BAA-4968-B913-8CB6D4328584Q37390649-E2A115E8-5017-47E0-AF00-3F86CF3848B3Q37447723-B97AEDC7-A292-4B3D-82B0-E2DB68569802Q37980263-43BD84F7-2978-48C0-89DA-299030708B41Q38267664-B4FBE689-E2F0-475E-BF79-F1EDA5DB3A0BQ38268611-2DE6CFF4-F58B-4D21-ABD9-B0CF86F8DD77Q38268965-7AECFA18-F3F7-4751-92F2-0F41F08F2151Q41914715-9712392E-A20A-4FA8-B904-9029AC1F7CD1Q42124714-B5C17673-E897-4DC3-AC23-E87CF9C3059FQ42200119-24D7B29D-0553-49A7-8E39-63CDF3F88FFEQ42490724-32276518-1684-4B5F-B300-EC63AB473CB3Q42591497-C32855B5-24B9-4A43-9E85-E5193157F771Q43239707-132EA1A9-434A-4923-A17E-9D965DB79849Q43512658-6FD9BD56-6BFD-4E10-9202-892E6C28D67DQ44332012-BE672334-993A-46F3-B6C7-C2269C39EA55Q45759197-2652529A-0739-42E2-8172-42736B81941EQ46169142-99899AEF-A163-4E7A-9D25-22D98EE9A3F0Q46251186-A4DC4B5F-C9DF-42F7-8FCF-AADC2E4DAF84Q46448098-71F78CEF-557A-4672-803C-595DA590D78A
P2860
Role of altered beta-adrenoceptor signal transduction in the pathogenesis of cirrhotic cardiomyopathy in rats.
description
1996 nî lūn-bûn
@nan
1996年の論文
@ja
1996年学术文章
@wuu
1996年学术文章
@zh-cn
1996年学术文章
@zh-hans
1996年学术文章
@zh-my
1996年学术文章
@zh-sg
1996年學術文章
@yue
1996年學術文章
@zh
1996年學術文章
@zh-hant
name
Role of altered beta-adrenocep ...... rhotic cardiomyopathy in rats.
@en
Role of altered beta-adrenocep ...... rhotic cardiomyopathy in rats.
@nl
type
label
Role of altered beta-adrenocep ...... rhotic cardiomyopathy in rats.
@en
Role of altered beta-adrenocep ...... rhotic cardiomyopathy in rats.
@nl
prefLabel
Role of altered beta-adrenocep ...... rhotic cardiomyopathy in rats.
@en
Role of altered beta-adrenocep ...... rhotic cardiomyopathy in rats.
@nl
P2093
P1433
P1476
Role of altered beta-adrenocep ...... rhotic cardiomyopathy in rats.
@en
P2093
P304
P356
10.1053/GAST.1996.V110.PM8613009
P407
P577
1996-04-01T00:00:00Z